Nov. 2, 2026 — Royal Philips has announced U.S. commercial availability of the HyperVue Integrated System1, a new single ...
Nov. 1, 2026 – Abbott has announced the 30-day results from the TECTONIC Coronary Artery Disease (CAD) Intravascular ...
Nov. 2, 2026 – Conavi Medical Corp. has announced the completion of the first U.S. placement and clinical cases with ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Nov. 1, 2026 — Heartflow, Inc. has announced new landmark randomized clinical data presented at Transcatheter ...
Oct. 29, 2026 — Johnson & Johnson has announced 26 presentations featuring the clinical science of Impella heart pumps ...
Oct. 27, 2026 — Atrium Therapeutics, developer of RNA therapeutics targeted to the heart, has announced that the first ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Oct. 27, 2026 — Monebo Technologies and Innolitics have announced that the U.S. Food and Drug Administration (FDA) has ...
Oct. 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) approval for the Amplatzer Paraclose PVL ...
Oct. 22, 2026 — For patients hospitalized with ischemic stroke and atrial fibrillation (AFib), restoring the heart’s ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Oct. 26, 2026 — Coreline Soft has received U.S. Food and Drug Administration (FDA) 510(k) clearance for AVIEW Aorta ...
Oct. 21, 2026 — Edwards Lifesciences Corp. recently announced that the U.S. Food and Drug Administration (FDA) has ...
Oct. 21, 2026 — The U.S. Food and Drug Administration (FDA) has cleared Elucid's FFR-IQ software for non-invasive ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Oct. 22, 2026 — Henry Ford Health has performed the first procedures globally in a clinical trial evaluating pulmonary ...
Oct. 20, 2026 — Penumbra, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has granted clearance ...
With a sirolimus-based drug-coated balloon (DCBs) entering the U.S. market, interventional cardiologists treating in ...
November 03, 2026
